Yannick Le Bris

Nantes, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival.

CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival.

Journal: Leukemia
Published: September 18, 2025

GPVI as a Potential New Biomarker for Myelofibrosis Diagnosis.

GPVI as a Potential New Biomarker for Myelofibrosis Diagnosis.

Journal: American journal of hematology
Published: June 27, 2025

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.

Journal: The New England journal of medicine
Published: February 12, 2025

Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Journal: Blood
Published: February 11, 2025

Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.

Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.

Journal: Leukemia
Published: October 31, 2024

Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome Screening.

Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome Screening.

Journal: International journal of laboratory hematology
Published: March 26, 2024

Susceptibility to mycobacterial infection in VEXAS syndrome.

Susceptibility to mycobacterial infection in VEXAS syndrome.

Journal: Rheumatology (Oxford, England)
Published: February 05, 2024

Obliteration of liver sinusoids through platelet aggregates associated to extramedullary haematopoiesis in myeloid neoplasms.

Obliteration of liver sinusoids through platelet aggregates associated to extramedullary haematopoiesis in myeloid neoplasms.

Journal: Virchows Archiv : an international journal of pathology
Published: January 05, 2024

Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.

Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.

Journal: Haematologica
Published: October 27, 2023

Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia.

Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia.

Journal: Blood advances
Published: October 12, 2023

Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.

Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.

Journal: American journal of hematology
Published: August 22, 2023

Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial.

Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial.

Journal: EClinicalMedicine
Published: July 06, 2023
Showing 1-12 of 56

Last Updated: 09/26/2026